Search
01/08/2024
Hospital pharmacy towards 2030
de Gamarra-Martínez, EF, Tortajada-Goitia, B, Corte-García, JJ, Martín-Herranz, I, García-Gil, M, de la Fuente, JS, Nicolás-Picó, J. Hospital pharmacy towards 2030. Farmacia Hospitalaria. 2024; 48DOI:10.1016/j.farma.2024.05.004. PMID:39097369. IF:(Q/D).
01/07/2024
Physicochemical Compatibility of Ceftolozane-Tazobactam with Parenteral Nutrition
De Pourcq, JT, Riera, A, Gras, L, Garin, N, Busquets, MA, Cardenete, J, Cardona, D, Riera, P. Physicochemical Compatibility of Ceftolozane-Tazobactam with Parenteral Nutrition. Pharmaceuticals. 2024; 17(7)DOI:10.3390/ph17070896. PMID:39065746. IF:4.800(Q1/2D).
01/07/2024
Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain
Abraldes, MJ, Calvo, P, Lechuga, MG, Merino, M, Lorenzo, TM, Maravilla-Herrera, P, Jiménez, BG, Ruiz-Moreno, JM. Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain. Ophthalmology and Therapy. 2024; 13(7)DOI:10.1007/s40123-024-00960-9. PMID:38771461. IF:3.200(Q1/2D).
01/07/2024
Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain
Ruiz-Moreno, JM, Lechuga, MG, Calvo, P, Merino, M, Lorenzo, TM, Maravilla-Herrera, P, Jiménez, BG, Abraldes, MJ. Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain. Ophthalmology and Therapy. 2024; 13(7)DOI:10.1007/s40123-024-00959-2. PMID:38771462. IF:3.200(Q1/2D).